CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,000 | -99.2% | 614 | -99.0% | 0.00% | – |
Q1 2021 | $121,000 | +57.1% | 61,300 | 0.0% | 0.00% | – |
Q4 2020 | $77,000 | -30.0% | 61,300 | 0.0% | 0.00% | – |
Q3 2020 | $110,000 | -73.1% | 61,300 | +25.6% | 0.00% | -100.0% |
Q2 2020 | $409,000 | +59.8% | 48,800 | 0.0% | 0.00% | – |
Q1 2020 | $256,000 | -3.8% | 48,800 | 0.0% | 0.00% | – |
Q4 2019 | $266,000 | +11.8% | 48,800 | 0.0% | 0.00% | – |
Q3 2019 | $238,000 | -29.6% | 48,800 | 0.0% | 0.00% | – |
Q2 2019 | $338,000 | -0.3% | 48,800 | 0.0% | 0.00% | – |
Q1 2019 | $339,000 | +18.9% | 48,800 | 0.0% | 0.00% | – |
Q4 2018 | $285,000 | -22.6% | 48,800 | 0.0% | 0.00% | – |
Q3 2018 | $368,000 | +49.6% | 48,800 | 0.0% | 0.00% | – |
Q2 2018 | $246,000 | -17.4% | 48,800 | 0.0% | 0.00% | – |
Q1 2018 | $298,000 | -13.9% | 48,800 | 0.0% | 0.00% | – |
Q4 2017 | $346,000 | +54.5% | 48,800 | +55.9% | 0.00% | – |
Q3 2017 | $224,000 | +13.7% | 31,300 | 0.0% | 0.00% | – |
Q2 2017 | $197,000 | – | 31,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
Platform Technology Partners | 33,750 | $9,000 | 0.01% |
PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
Aries Wealth Management | 15,400 | $4,000 | 0.00% |